ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,785,000 | -97.8% | 20,000 | -97.4% | 0.01% | -98.0% |
| Q1 2023 | $82,678,414 | +80.7% | 771,110 | +105.8% | 0.26% | +64.1% |
| Q4 2022 | $45,763,332 | +15.4% | 374,710 | -2.5% | 0.16% | -1.3% |
| Q3 2022 | $39,672,000 | +1119.2% | 384,200 | +997.7% | 0.16% | +1028.6% |
| Q2 2022 | $3,254,000 | -78.4% | 35,000 | -68.8% | 0.01% | -76.7% |
| Q4 2021 | $15,094,000 | +2.6% | 112,200 | +21.5% | 0.06% | -7.7% |
| Q3 2021 | $14,713,000 | +31.4% | 92,309 | +8.5% | 0.06% | +30.0% |
| Q2 2021 | $11,195,000 | +148.2% | 85,100 | +143.1% | 0.05% | +138.1% |
| Q1 2021 | $4,511,000 | -35.1% | 35,000 | -16.1% | 0.02% | -38.2% |
| Q4 2020 | $6,955,000 | -14.9% | 41,700 | -42.6% | 0.03% | -48.5% |
| Q1 2020 | $8,175,000 | – | 72,600 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |